People

Dance Biopharm, which is developing an insulin soft mist inhaler, has named Melissa Rhodes as Chief Development Officer and Michael Kaseta as its new Chief Financial Officer. The company said that former CFO Don Huffman will continue to act as an advisor. Rhodes was most recently Chief Development Officer at Roivant's Altavant Sciences and was previously Senior VP … [Read more...] about Dance Biopharm appoints new CFO and Chief Development Officer

Inhaler filling experts Harro Höfliger have announced a number of management changes after the retirement of its founder, Harro Höfliger, who has been succeeded by his son, Markus Höfliger as Chairman of the Supervisory Board. Markus Höfliger was formerly Chief Financial Officer; Turgay Güngormus will now take over as CFO. According to the company, Harro Höfliger … [Read more...] about Harro Höfliger announces management changes

Nanoform, which recently announced construction of a new GMP manufacturing facility in Helsinki, has announced the appointment of Niklas Sandler as Chief Technology Officer. Sandler was most recently Vice Rector responsible for Research Affairs and Professor of Pharmaceutical Technology at Åbo Akademi University, and he is Chairman of the Board of the Finnish … [Read more...] about Nanoform appoints Niklas Sandler as Chief Technology Officer

Verona Pharma, which is developing an inhaled PDE3/PDE4 inhibitor, has named Kathleen Rickard as Chief Medical Officer and Tara Rheault as VP of Research and Development Operations and Global Project Management. Rickard has previously served as Chief Medical Officer at Aerocrine, Head of Clinical Development at Circassia, and VP Clinical Development and Medical … [Read more...] about Verona Pharma names Kathleen Rickard as CMO and Tara Rheault as VP of R&D

Finnish nanotechnology company Nanoform has named Gonçalo Rebelo de Andrade, former Hovione Business Development Manager for inhalation and respiratory product development, as Chief of Business Operations. The company recently announced that it is building a new 600m2 GMP manufacturing facility in Helsinki. Andrade also served as Managing Director of Hovione … [Read more...] about Nanoform appoints Gonçalo Rebelo de Andrade as Chief of Business Operations

AOBiome Therapeutics, which is developing several intranasal ammonia oxidizing bacteria (AOB) candidates, said that Judith Ng-Cashin was appointed Chief Medical Officer as of October 1, 2018. Ng-Cashin was most recently Chief Scientific Officer at Syneos Health. She has also held a variety of executive positions at IQVIA (formerly Quintiles) and GSK. In April … [Read more...] about AOBiome Therapeutics names Judith Ng Cashin as Chief Medical Officer

CDMO MedPharm has announced the appointment of former DPT Laboratories executive Eugene Ciolfi as President and CEO, replacing Co-Founder Andy Muddle, who will remain "in an ambassadorial role." Ciolfi was most recently VP and Site Head at Torrent Pharma. According to MedPharm, Ciolfi will guide the company as it expands into commercial manufacturing and new … [Read more...] about MedPharm appoints Eugene Ciolfi as President and CEO

Insmed Incorporated has announced that its Chairman of the Board Donald Hayden, Jr is stepping down as chairman and will be replaced by Insmed President and CEO Will Lewis. Hayden, who served as chairman for 13 years, will continue as a director. Former AstraZeneca CEO David Brennan has been elected as lead independent director. In addition, former Johnson & … [Read more...] about Insmed CEO Will Lewis becomes chairman of the board as Donald Hayden, Jr steps down

Intranasal drug developer Impel NeuroPharma has announced the appointment of former Allergan VP of External Science & Innovation Ellen A. Lubman as Chief Business Officer. Her previous experience also includes stints at Kadmon Pharmaceuticals and Bristol-Myers Squibb. According to the company, Lubman will head up partnering and acquisition activities. In August … [Read more...] about Impel NeuroPharma appoints Ellen A. Lubman as Chief Business Officer